TP53 and cancer: First, we discovered that variants in the splice acceptor signal position NM_000546_c.673-2 are specifically enriched in CLL compared to all other cancer types and found predominantly in patients carrying multiple TP53 variants, a specific feature observed both in the FILO dataset and in UMD_CLL.